CM
CM Management Portfolio holdings
AUM
$110M
This Quarter Return
-3.12%
1 Year Return
+9.76%
3 Year Return
+99.54%
5 Year Return
–
10 Year Return
–
AUM
$112M
AUM Growth
+$112M
(-11%)
Cap. Flow
-$6.82M
Cap. Flow
% of AUM
-6.09%
Top 10 Holdings %
Top 10 Hldgs %
38.7%
Holding
66
New
2
Increased
18
Reduced
11
Closed
9
Top Buys
| 1 |
Hasbro
HAS
|
$1.12M |
| 2 |
Copa Holdings
CPA
|
$1.1M |
| 3 |
Freeport-McMoran
FCX
|
$762K |
| 4 |
Organon & Co
OGN
|
$746K |
| 5 |
Pan American Silver
PAAS
|
$607K |
Top Sells
| 1 |
Kyndryl
KD
|
$3.22M |
| 2 |
Pfizer
PFE
|
$1.74M |
| 3 |
Herc Holdings
HRI
|
$1.28M |
| 4 |
Warner Bros
WBD
|
$1.11M |
| 5 |
Perrigo
PRGO
|
$1.05M |
Sector Composition
| 1 | Healthcare | 39.52% |
| 2 | Materials | 10.9% |
| 3 | Industrials | 10.07% |
| 4 | Technology | 9.2% |
| 5 | Financials | 8.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Alico
ALCO
$259M
| $5.83M | 5.21% | 225,000 | – | – |
|
2
Radiant Logistics
RLGT
$305M
| $5.19M | 4.64% | 775,000 | – | – |
|
|
TGB
3
Taseko Mines
TGB
$1.03B
| $4.75M | 4.24% | 2,450,000 | – | – |
|
4
ClearPoint Neuro
CLPT
$298M
| $4.46M | 3.98% | 290,000 -10,000 | -3% | -$154K |
|
5
Amicus Therapeutics
FOLD
$2.34B
| $4.24M | 3.79% | 450,000 | – | – |
|
6
Royalty Pharma
RPRX
$15.6B
| $4.08M | 3.65% | 160,000 | – | – |
|
7
Rigel Pharmaceuticals
RIGL
$697M
| $4.08M | 3.64% | 242,500 -47,500 | -16% | -$799K |
|
8
Newmark Group
NMRK
$3.22B
| $3.84M | 3.43% | 300,000 | – | – |
|
9
Preformed Line Products
PLPC
$941M
| $3.45M | 3.08% | 27,000 | – | – |
|
10
Talos Energy
TALO
$1.73B
| $3.4M | 3.04% | 350,000 | – | – |
|
11
ARKO Corp
ARKO
$564M
| $3.24M | 2.89% | 1,050,000 +30,000 | +3% | +$92.4K |
|
12
inTEST
INTT
$87.3M
| $3.14M | 2.8% | 365,000 +15,000 | +4% | +$129K |
|
13
Coherus Oncology, Inc. Common Stock
CHRS
$135M
| $2.83M | 2.53% | 2,050,000 +50,000 | +3% | +$69K |
|
14
PagerDuty
PD
$1.54B
| $2.74M | 2.45% | 150,000 | – | – |
|
|
15
Copa Holdings
CPA
$4.83B
| $2.64M | 2.35% | 30,000 +12,500 | +71% | +$1.1M |
|
16
Sabre
SABR
$706M
| $2.56M | 2.28% | 700,000 +50,000 | +8% | +$183K |
|
17
BGC Group
BGC
$4.65B
| $2.49M | 2.23% | 275,000 | – | – |
|
18
Viatris
VTRS
$12.3B
| $2.49M | 2.22% | 200,000 | – | – |
|
19
Republic Bancorp
RBCAA
$1.5B
| $2.45M | 2.18% | 35,000 | – | – |
|
|
20
Organon & Co
OGN
$2.45B
| $2.24M | 2% | 150,000 +50,000 | +50% | +$746K |
|
21
Iovance Biotherapeutics
IOVA
$807M
| $2.22M | 1.98% | 300,000 +50,000 | +20% | +$370K |
|
22
Ark Restaurants
ARKR
$24.6M
| $2.2M | 1.96% | 200,000 | – | – |
|
23
Brookline Bancorp
BRKL
$976M
| $2.12M | 1.9% | 180,000 -45,000 | -20% | -$531K |
|
24
Park Hotels & Resorts
PK
$2.35B
| $2.11M | 1.88% | 150,000 | – | – |
|
|
CGAU
25
Centerra Gold
CGAU
$1.66B
| $1.99M | 1.78% | 350,000 | – | – |
|